Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan.
Hitoshi TajiriKatsuhiro AraiSeiichi KagimotoReiko KunisakiNobuyuki HidaNoriko SatoHiroshi YamadaMieko NaganoYutaka SusutaKunihiko OzakiKazuoki KondoToshifumi HibiPublished in: BMC pediatrics (2019)
ClinicalTrials.gov, registration number: NCT01585155 .